S. Jolly

1.4k total citations · 1 hit paper
27 papers, 1.0k citations indexed

About

S. Jolly is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, S. Jolly has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pathology and Forensic Medicine. Recurrent topics in S. Jolly's work include Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Ischemia and Reperfusion (6 papers) and Cardiac Imaging and Diagnostics (3 papers). S. Jolly is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Ischemia and Reperfusion (6 papers) and Cardiac Imaging and Diagnostics (3 papers). S. Jolly collaborates with scholars based in United States, China and Czechia. S. Jolly's co-authors include Benedict R. Lucchesi, Gerald D. Abrams, Marc B. Bailie, William J. Kane, G J Gross, Larry R. Bush, Marshal Shlafer, R.G. Van Inwegen, Harold F. Hardman and Robert J. Gordon and has published in prestigious journals such as Circulation Research, European Heart Journal and Journal of Lipid Research.

In The Last Decade

S. Jolly

25 papers receiving 973 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

1984 738 citations S. Jolly, William J. Kane et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Jolly United States	10	520	354	233	192	175	27	1.0k
Carlo Duilio Italy	10	433 0.8×	295 0.8×	397 1.7×	234 1.2×	142 0.8×	24	1.1k
Edward M. Driscoll United States	19	312 0.6×	512 1.4×	201 0.9×	118 0.6×	111 0.6×	41	1.1k
Karen P. Burton United States	14	443 0.9×	348 1.0×	351 1.5×	172 0.9×	151 0.9×	22	1.0k
Nancy H. Manson United States	8	430 0.8×	289 0.8×	323 1.4×	150 0.8×	123 0.7×	10	848
J. A. Rousou United States	19	635 1.2×	351 1.0×	449 1.9×	193 1.0×	214 1.2×	30	1.4k
R Bolli United States	6	315 0.6×	222 0.6×	158 0.7×	143 0.7×	127 0.7×	8	700
Stanley B. Digerness United States	16	389 0.7×	235 0.7×	234 1.0×	132 0.7×	175 1.0×	34	902
Pietro Paolo Elia Italy	6	326 0.6×	126 0.4×	334 1.4×	170 0.9×	129 0.7×	8	1.1k
Gregory K. Asimakis United States	21	478 0.9×	197 0.6×	610 2.6×	241 1.3×	243 1.4×	39	1.2k
Roger J. Willis Australia	17	220 0.4×	255 0.7×	166 0.7×	81 0.4×	77 0.4×	50	687

Countries citing papers authored by S. Jolly

Since Specialization

Citations

This map shows the geographic impact of S. Jolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jolly more than expected).

Fields of papers citing papers by S. Jolly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jolly. The network helps show where S. Jolly may publish in the future.

Co-authorship network of co-authors of S. Jolly

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jolly. A scholar is included among the top collaborators of S. Jolly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jolly. S. Jolly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schipper, M., M.M. Matuszak, Mark M. Zaki, et al.. (2025). Optimizing Fractionation Strategies for Early-Stage NSCLC: Real-World Toxicity and Outcomes from a Statewide Consortium. International Journal of Radiation Oncology*Biology*Physics. 123(1). e165–e165.

Ray, D., S. Jolly, David Karnak, et al.. (2020). Predicting Radiation Pneumonitis Using Plasma Biomarkers Related to TNFα-NFκB Pathway. International Journal of Radiation Oncology*Biology*Physics. 108(3). e570–e570. 1 indexed citations

Xue, Jianxin, Cheng‐Bo Han, Andrew Jackson, et al.. (2018). Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer. Radiotherapy and Oncology. 133. 213–219. 35 indexed citations

Jolly, S., B.R. Mancini, James A. Hayman, et al.. (2018). Heterogeneity in the Treatment of Bone Metastases: A Contemporary Statewide Practice Pattern Analysis. International Journal of Radiation Oncology*Biology*Physics. 102(3). e443–e443. 1 indexed citations

Cui, Sunan, Yunan Luo, S. Jolly, Randall K. Ten Haken, & Issam El Naqa. (2018). Prediction of Local Control in Non-Small Cell Lung Cancer Patients after Radiation Therapy by Composite Deep Learning Neural Networks. International Journal of Radiation Oncology*Biology*Physics. 102(3). S4–S5. 1 indexed citations

Hawkins, Peter G., Ying‐ying Sun, Robert T. Dess, et al.. (2018). Circulating microRNAs as Biomarkers of Radiation-Induced Cardiac Toxicity in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). S139–S139. 8 indexed citations

Naqa, Issam El, Daniel L. McShan, Ines Lohse, et al.. (2016). Response-based Bayesian Network Approaches for Adaptive Radiotherapy of Non-Small Cell Lung Cancer (NSCLC). Radiotherapy and Oncology. 118. S100–S101. 1 indexed citations

Jolly, S., et al.. (2003). Dynamic frequency spectrum analysis: application in organized and disorganized electrocardiographic signals. 6. 461–464. 2 indexed citations

Jolly, S., et al.. (2002). Frequency analysis: a potential method to differentiate ventricular fibrillation of various etiologies. 519–521. 1 indexed citations

10.

Jolly, S., J. Travis, & R.G. Van Inwegen. (1989). Effects of 5-Lipoxygenase Inhibition on Cardiac Anaphylaxis in Isolated Guinea Pig Hearts. Pharmacology. 38(6). 352–362. 4 indexed citations

11.

Pohl, R. O., et al.. (1988). Preinfusion anxiety and laboratory-induced panic attacks in panic disorder patients.. PubMed. 49(8). 302–6. 7 indexed citations

12.

Inwegen, R.G. Van, et al.. (1987). REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile.. Journal of Pharmacology and Experimental Therapeutics. 241(1). 117–124. 33 indexed citations

13.

Jolly, S., William J. Kane, Marc B. Bailie, Gerald D. Abrams, & Benedict R. Lucchesi. (1984). Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.. Circulation Research. 54(3). 277–285. 738 indexed citations breakdown →

14.

Murtagh, James J., Edward M. Driscoll, S. Jolly, et al.. (1983). Beneficial Effects of Nafazatrom in Experimental Models of Coronary Thrombosis and Myocardial Ischemia. European Heart Journal. 4(suppl B). 2–2. 1 indexed citations

15.

Murtagh, James J., et al.. (1983). Beneficial Effects of Nafazatrom in Experimental Models of Coronary Thrombosis and Myocardial Ischemia. European Heart Journal. 4(suppl B). 2–2. 1 indexed citations

16.

Jolly, S., Gerald D. Abrams, Joseph L. Romson, Marc B. Bailie, & Benedict R. Lucchesi. (1982). Effects of Lodoxamide on Ischemic Reperfused Myocardium. Journal of Cardiovascular Pharmacology. 4(3). 441–448. 29 indexed citations

17.

Jolly, S., Harold F. Hardman, & G J Gross. (1981). Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.. Journal of Pharmacology and Experimental Therapeutics. 217(1). 20–25. 21 indexed citations

18.

Bush, Larry R., et al.. (1981). Protective effects of diltiazem during myocardial ischemia in isolated cat hearts.. Journal of Pharmacology and Experimental Therapeutics. 218(3). 653–661. 50 indexed citations

19.

Jolly, S., Yolanda B. Lombardo, John J. Lech, & Lawrence A. Menahan. (1980). Effect of aging and cellularity on lipolysis in isolated mouse fat cells.. Journal of Lipid Research. 21(1). 44–52. 12 indexed citations

20.

Jolly, S. & G J Gross. (1980). Improvement in ischemic myocardial blood flow following a new calcium antagonist. American Journal of Physiology-Heart and Circulatory Physiology. 239(2). H163–H171. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact